Skip to content Skip to menu

Industry supporting global immunisation effort

Monday, 23 May 2011

Media Release

Medicines Australia welcomes Bill Gates’ support for strengthened global immunisation programs against infectious diseases.

Speaking at the World Health Assembly in Geneva last week, Mr Gates praised pharmaceutical companies, global health organisations and governments for their work in providing access to new vaccines in developing countries.

Mr Gates told the assembly that vaccines are the best possible investment in global health.

“They can be inexpensive, they are easy to deliver and they are proven to protect children from disease,” Mr Gates said.

Medicines Australia chief executive Dr Brendan Shaw said strengthening programs for immunisation against infectious disease could save millions of lives.

“The medicines industry is committed to investing in the development of innovative, safe and effective vaccines and making them available through partnerships.

“The innovative vaccines industry has long been working with the global immunisation community, to ensure every country has access to these vaccines through sustainable immunisation programs.

“Medicines Australia members are among the companies working at a global level with governments, NGOs and private foundations to make vaccines available at a price those governments can afford.

“Medicines Australia welcomes Mr Gates’ recognition of the contribution the medicines industry is making to solve the world’s global health problems through the development and supply of new vaccines.”

Over the last decade, the biopharmaceutical research sector has invested over $9.2 billion in direct assistance to improve healthcare throughout the developing world.

Innovative pharmaceutical companies are today working on nearly 400 new medicines and vaccines to combat infectious diseases. Many of these medicines are already in late-stage clinical trials or being considered by the US Food and Drug Administration (FDA) for approval for patient use.

Bill Gates’ address to the World Health Assembly is available here

–ENDS–

Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293
Email:
Jamie.Nicholson@medicinesaustralia.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top